Targeting the PI3K–Akt–mTOR Pathway in Cancers: Impact on Tumor Cells and Their Microenvironments
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (25 December 2023) | Viewed by 3080
Special Issue Editors
Interests: cancer; osteosarcoma; small round cell tumor; tumor microenvironment
Interests: molecular and cellular mechanisms underlie tumor growth and metastasis; interplay between tumour cells and cells of the tumour microenvironment; PI3K-isoform specific signalling
Special Issue Information
Dear Colleagues,
Increasing evidence has emerged suggesting that the PI3K–Akt–mTOR pathway is a critical driver of cancer progression. Tumors consist not only of cancer cells but also multiple residents or infiltrating normal host cells that comprise the tumor microenvironment (TME). The interactions of cancer cells with cells of the TME determine whether the primary tumor is regressing or progressing and metastasizing. Selective pharmacological inhibitors against molecular components of the PI3K–Akt–mTOR pathway have played critical roles in regulating TME cell fate and the differentiation of cancer cells. The clinical outcome of various hematologic and solid cancers has been improved by overcoming the resistance mechanisms generated through the blockade of one of these components. In addition, several preclinical studies using PI3K–Akt–mTOR inhibitors in combination have reported successful synergistic strategies.
This Special Issue aims to bridge the bibliographic history of the PI3K–Akt–mTOR pathway with new compelling therapeutic opportunities. We invite our colleagues to submit their original research articles and reviews considering new therapeutic approaches or novel targets of the mechanism of resistance to PI3K–Akt–mTOR to improve the effectiveness of existing cancer treatment in the clinic. We also encourage the submission of articles exploring the effects of new drugs that are under development in preclinical or translational evaluations for their impact on PI3K–Akt–mTOR and other crosstalk signaling pathways regulating cell proliferation, cell fate, metastasis, and other biological processes controlling tumor progression.
Dr. Salah-Eddine Lamhamedi-Cherradi
Dr. Evangelia A. Papakonstanti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PI3K
- PI3K isoforms
- Akt
- mTOR
- cancer cells
- tumor microenvironment
- angiogenesis
- cancer immunotherapy
- solid tumors
- hematologic malignancies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
